The global montelukast drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The montelukast drug is a leukotriene inhibitor that is used to prevent asthma attacks in adults and children at least 2 years old. The rise in the incidence of asthma is anticipated to accelerate the growth of […]